Harlan Robins is solving scientific puzzles to improve the way the health care industry diagnoses, monitors and treats diseases around the globe. His company, Adaptive Biotechnologies, has pioneered a patented immunosequencing technology that leverages next-generation sequencing to profile T-cell and B-cell receptors of the adaptive immune system.
Adaptive Biotechnologies
